المؤلفون: Tadafumi NISHIMURA, Ryochi FUJII, Toshiaki ABE, Hidenori MEGURO, Fujiaki HIRUMA, Makoto HORI, Osamu TATSUZAWA, Kihei MAEKAWA, Noriyuki WADA, Masakatsu KUBO, Yoshikiyo TOYONAGA, Susumu NAKAZAWA, Hajime SATO, Kenji NIINO, Haruo ICHIHASHI, Ken-ichi MIKUNI, Shintaro TAKAHASHI, Yasuko ISHIKAWA, Hiroshi HIROSAWA, Mikio MINAMITANI, Kei HACHIMORI, Keisuke SUNAGAWA, Hironobu AKITA, Tadashi OJIMA, Yoshitake SATO, Satoshi IWATA, Naoichi IWAI, Haruhi NAKAMURA, Kuniyoshi KUNO, Minoru SAKURAI, Hitoshi KAMIYA, Shojiro ARAI, Haruki MIKAWA, Mitsufumi MAYUMI, Kazuo TABUKI, Yohnosuke KOBAYASHI, Hirohiko HIGASHINO, Yutaka KOBAYASHI, Tsutomu TSUTSUI, Tsunekazu HARUTA, Hisaaki ARAKI, Shinya KANEKO, Koji MATSUMOTO, Takashi MOTOHIRO, Yasutaka SAKATA, Akira KAWAKAMI, Masafumi ARAMAKI, Fumio YAMASHITA, Masanori YANAI, Akira OMIYA, Yoshiro TSUJI

المصدر: Journal of the Japanese Association for Infectious Diseases. 64:34-53

مصطلحات موضوعية: Pediatrics, medicine.medical_specialty, Lymphoma, Combination therapy, I v administration, medicine.drug_class, Antibiotics, Drug Administration Schedule, Refractory, Central Nervous System Diseases, medicine, Humans, Multicenter Studies as Topic, Child, Fulminant hepatitis, Respiratory Tract Infections, Clinical Trials as Topic, Leukemia, biology, business.industry, Anemia, Aplastic, Bacterial Infections, General Medicine, Therapeutic evaluation, Rash, Anti-Bacterial Agents, Immunoglobulin G, Injections, Intravenous, Urinary Tract Infections, biology.protein, Drug Therapy, Combination, medicine.symptom, Antibody, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69499c4aec5457b11d66034da0c7a3ac
https://doi.org/10.11150/kansenshogakuzasshi1970.64.34